Occidental Q1 2026 reported EPS $3.13, adjusted EPS $1.06 after OxyChem sale gain
Occidental reported first-quarter 2026 net income attributable to common stockholders of $3.2 billion, or $3.13 per diluted share, and adjusted EPS from continuing operations of $1.06. The reported profit was driven by the gain on the OxyChem sale within discontinued operations, while adjusted EPS fell from $2.21 in the fourth quarter of 2025, and the company said it repaid $7.1 billion of principal debt through May 5.
Key points
- Net sales were $5,230 million, up from $5,112 million in the fourth quarter of 2025 and down from $5,704 million in the first quarter of 2025.
- Adjusted EPS from continuing operations was $1.06, compared with $2.21 in the fourth quarter of 2025 and $0.87 in the first quarter of 2025.
- Total company production of 1,426 Mboed exceeded the high end of guidance, and midstream and marketing adjusted pre-tax income exceeded the high end of guidance.
- Principal debt was reduced to $13.3 billion, with $7.1 billion repaid through May 5, 2026, and the company is progressing toward a $10.0 billion milestone.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.